|
The growing healthcare industry at global as well as regional level forms the basis of our coherent and strategically structured market research reports. We segment our healthcare industry reports into Pharma, Vaccine, Biotech, Healthcare, and Generic Drugs.
Our elaborate healthcare industry reports contain comprehensive analytical as well as statistical information on various issues, including cost analysis, intellectual property, infrastructure, healthcare equipment, health insurance market, and hospital services. We thoroughly analyze new vistas being opened by the strongly growing healthcare industry, like contract manufacturing, clinical trials, drug delivery devices, and healthcare insurance.
Our research analysts evaluate data using sophisticated tools to provide viable and effective business solutions that help clients to plan their investment activities accordingly.
|
|
|
 |
| US Healthcare Sector Forecast to 2012 |
| Nov, 2009 | Pages : 55 |
| The US represents the world’s largest healthcare market, with an annual spending of around US$ 2.24 Trillion in 2007. The US healthcare spending is expected to grow at a CAGR of around 4%....
read more |
|
Buy Now
US$ 1000.00
|
|
 |
| China Healthcare Sector Analysis |
| Oct, 2009 | Pages : 105 |
| The Chinese healthcare spending is forecast to grow at CAGR of over 18% during 2010-2012. The market is characterized by major changes in rural healthcare infrastructure....
read more |
|
Buy Now
US$ 1200.00
|
|
 |
| Booming Clinical Trials Market in India |
| Sep, 2009 | Pages : 85 |
| The clinical trial outsourced market in India is forecasted to grow at a CAGR of around 31% during 2010-2012. Presently, the market is characterized by the dominance of phase III and phase II trials,...
read more |
|
Buy Now
US$ 1200.00
|
|
|
|
 |
| Booming US Generic Drug Market |
| Aug, 2009 | Pages : 70 |
| Over the past ten years the generic drugs have saved US$ 734 Billion for the American healthcare system. The US generics market is forecasted to grow at a CAGR of around 9.2% during 2010-2012....
read more |
|
Buy Now
US$ 1200.00
|
|
|
|
|
|
|
|